Oritavancin Diphosphate and Recombinate recombinant
Determining the interaction of Oritavancin Diphosphate and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oritavancin
Brand name: Orbactiv
Synonyms: Oritavancin
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oritavancin Diphosphate-Recombivax
- Oritavancin Diphosphate-Recombivax HB
- Oritavancin Diphosphate-Recombivax HB Adult
- Oritavancin Diphosphate-Recombivax HB Dialysis Formulation
- Oritavancin Diphosphate-Recombivax HB Pediatric/Adolescent
- Oritavancin Diphosphate-Recort Plus
- Recombinate recombinant-Oritavancin Intravenous
- Recombinate recombinant-Orkambi
- Recombinate recombinant-Orkambi (Lumacaftor and Ivacaftor Granules)
- Recombinate recombinant-Orkambi (Lumacaftor and Ivacaftor Tablets)
- Recombinate recombinant-Orlistat
- Recombinate recombinant-Ornex